van Rosmalen J - Search Results

1

Exploring the trend of increased cervical intraepithelial neoplasia detection rates in the Netherlands.

Rozemeijer K, van Kemenade FJ, Penning C, Matthijsse SM, Naber SK, van Rosmalen J, van Ballegooijen M, de Kok IM. Rozemeijer K, et al. Among authors: van rosmalen j, van kemenade fj, van ballegooijen m. J Med Screen. 2015 Sep;22(3):144-50. doi: 10.1177/0969141315580836. Epub 2015 May 14. J Med Screen. 2015. PMID: 25977375

2

Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?

de Kok IM, Habbema JD, van Rosmalen J, van Ballegooijen M. de Kok IM, et al. Among authors: van rosmalen j, van ballegooijen m. Eur J Cancer. 2011 Feb;47(3):428-35. doi: 10.1016/j.ejca.2010.09.030. Eur J Cancer. 2011. PMID: 20971633

3

Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts.

O'Mahony JF, de Kok IM, van Rosmalen J, Habbema JD, Brouwer W, van Ballegooijen M. O'Mahony JF, et al. Among authors: van rosmalen j, van ballegooijen m. Value Health. 2011 Jun;14(4):438-42. doi: 10.1016/j.jval.2010.09.009. Epub 2011 May 19. Value Health. 2011. PMID: 21669368 Free article.

4

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.

van Rosmalen J, de Kok IM, van Ballegooijen M. van Rosmalen J, et al. Among authors: van ballegooijen m. BJOG. 2012 May;119(6):699-709. doi: 10.1111/j.1471-0528.2011.03228.x. Epub 2012 Jan 18. BJOG. 2012. PMID: 22251259 Free PMC article.

5

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.

de Kok IM, van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T, van Ballegooijen M. de Kok IM, et al. Among authors: van rosmalen j, van ballegooijen m. BMJ. 2012 Mar 5;344:e670. doi: 10.1136/bmj.e670. BMJ. 2012. PMID: 22391612 Free PMC article.

6

Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis.

de Bekker-Grob EW, de Kok IM, Bulten J, van Rosmalen J, Vedder JE, Arbyn M, Klinkhamer PJ, Siebers AG, van Ballegooijen M. de Bekker-Grob EW, et al. Among authors: van rosmalen j, van ballegooijen m. Cancer Causes Control. 2012 Aug;23(8):1323-31. doi: 10.1007/s10552-012-0011-1. Epub 2012 Jun 17. Cancer Causes Control. 2012. PMID: 22706692 Clinical Trial.

7

Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information.

O'Mahony JF, van Rosmalen J, Zauber AG, van Ballegooijen M. O'Mahony JF, et al. Among authors: van rosmalen j, van ballegooijen m. Med Decis Making. 2013 Apr;33(3):407-14. doi: 10.1177/0272989X12453503. Epub 2012 Aug 27. Med Decis Making. 2013. PMID: 22927697 Free PMC article.

8

Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study.

Rebolj M, Helmerhorst T, Habbema D, Looman C, Boer R, van Rosmalen J, van Ballegooijen M. Rebolj M, et al. Among authors: van rosmalen j, van ballegooijen m. BMJ. 2012 Oct 31;345:e6855. doi: 10.1136/bmj.e6855. BMJ. 2012. PMID: 23117059 Free PMC article.

9

How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age?

de Kok IM, van Rosmalen J, Rozemeijer K, Penning C, van Ballegooijen M. de Kok IM, et al. Among authors: van rosmalen j, van ballegooijen m. Int J Cancer. 2014 Jan 15;134(2):460-6. doi: 10.1002/ijc.28366. Epub 2013 Aug 5. Int J Cancer. 2014. PMID: 23824905

10

Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits?

Rozemeijer K, de Kok IM, Naber SK, van Kemenade FJ, Penning C, van Rosmalen J, van Ballegooijen M. Rozemeijer K, et al. Among authors: van rosmalen j, van kemenade fj, van ballegooijen m. Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):773-82. doi: 10.1158/1055-9965.EPI-14-0998. Epub 2014 Nov 28. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25432954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters